NASDAQ:JUNO Investor Alert: Lawsuit Filed in Effort to Halt the Takeover of Juno Therapeutics Inc

San Diego, CA -- (SBWIRE) -- 02/20/2018 -- The Shareholders Foundation announces that an investor, who currently holds NASDAQ:JUNO shares, filed a lawsuit in against the proposed takeover of Juno Therapeutics Inc. by Celgene Corporation for $87 per share.